Insider Trading & Ownership of Robert Nelsen

Location: Chicago, IL
Summary: The estimated net worth of Robert Nelsen is at least $341,164,193 dollars as of 05 Aug 2025. Robert Nelsen is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $178.33M. Robert Nelsen is the Director, 10%+ Owner of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $83.02M. Robert Nelsen is the Director, 10%+ Owner of Prime Medicine, Inc. and owns shares of Prime Medicine, Inc. (PRME) stock worth about $73.95M. Robert Nelsen is the Director of Vir Biotechnology, Inc. and owns shares of Vir Biotechnology, Inc. (VIR) stock worth about $5.87M.
Signature: /s/ Ryan Brown, attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when Robert Nelsen files a new Insider Trading report.

Ownership of Robert Nelsen

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
DNLI	Denali Therapeutics Inc.	Director	$178,327,354			02 Jun 2021
LYEL	Lyell Immunopharma, Inc.	Director, 10%+ Owner	$83,020,992			14 Jun 2024
PRME	Prime Medicine, Inc.	Director, 10%+ Owner	$73,946,120	+$9,999,990	+16%	01 Aug 2025
VIR	Vir Biotechnology, Inc.	Director	$5,869,727			30 May 2024
SANA	Sana Biotechnology, Inc.	Director, 10%+ Owner				05 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.